Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space. 

Biotechnology

Genevant Sciences

Pete Lutwyche

Gregg Ashby

James Heyes

Pete Zorn

Ed Yaworski

Tracy Meffen

Genevant Sciences' CEO and Executive Team includes Pete Lutwyche and 2 others.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Genevant Sciences

Leadership Team